Presentation Information
[28-09-am10S]Chronopharmacological approach for optimization of the dose schedule of the HER2-targeted antibody drug conjugate, Trastuzumab-Deruxtecan
○Sayaka Takeda1, Nakao Nodoka1, Tomoaki Yamauchi1, Mai Haraguchi1, Yuji Omata1, Akito Tsuruta1, Satoru Koyanagi1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.